Envestnet Asset Management’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.6M Sell
879,874
-11,309
-1% -$175K ﹤0.01% 1529
2025
Q1
$13.3M Sell
891,183
-93,495
-9% -$1.39M ﹤0.01% 1469
2024
Q4
$13M Sell
984,678
-460,843
-32% -$6.1M ﹤0.01% 1468
2024
Q3
$20.6M Sell
1,445,521
-37,972
-3% -$540K 0.01% 1170
2024
Q2
$19.2M Sell
1,483,493
-45,894
-3% -$594K 0.01% 1151
2024
Q1
$21.2M Sell
1,529,387
-59,426
-4% -$825K 0.01% 1071
2023
Q4
$22.7M Buy
1,588,813
+75,877
+5% +$1.08M 0.01% 963
2023
Q3
$23.4M Buy
1,512,936
+81,267
+6% +$1.26M 0.01% 891
2023
Q2
$22.5M Sell
1,431,669
-3,267,934
-70% -$51.3M 0.01% 871
2023
Q1
$19.3M Buy
4,699,603
+3,593,286
+325% +$14.7M 0.01% 902
2022
Q4
$17.3M Buy
1,106,317
+216,445
+24% +$3.38M 0.01% 929
2022
Q3
$11.5M Buy
889,872
+325,262
+58% +$4.22M 0.01% 1061
2022
Q2
$7.93M Buy
564,610
+67,610
+14% +$949K ﹤0.01% 1278
2022
Q1
$7.12M Buy
497,000
+68,166
+16% +$976K ﹤0.01% 1407
2021
Q4
$5.85M Sell
428,834
-4,724
-1% -$64.4K ﹤0.01% 1508
2021
Q3
$7.1M Buy
433,558
+21,600
+5% +$354K ﹤0.01% 1333
2021
Q2
$6.93M Sell
411,958
-35,065
-8% -$590K ﹤0.01% 1328
2021
Q1
$8.16M Buy
447,023
+18,607
+4% +$340K 0.01% 1164
2020
Q4
$7.8M Buy
428,416
+68,397
+19% +$1.24M 0.01% 1043
2020
Q3
$6.42M Buy
360,019
+250
+0.1% +$4.46K 0.01% 1031
2020
Q2
$6.45M Buy
359,769
+4,234
+1% +$75.9K 0.01% 991
2020
Q1
$5.4M Buy
355,535
+54,732
+18% +$831K 0.01% 955
2019
Q4
$5.94M Buy
300,803
+18,967
+7% +$374K 0.01% 1041
2019
Q3
$4.85M Buy
281,836
+28,318
+11% +$487K 0.01% 1083
2019
Q2
$4.49M Buy
253,518
+55,187
+28% +$977K 0.01% 1111
2019
Q1
$4.04M Buy
198,331
+87,781
+79% +$1.79M 0.01% 1117
2018
Q4
$1.86M Buy
+110,550
New +$1.86M ﹤0.01% 1382